Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Ryman Healthcare's share price for the quarter that ended in Mar. 2025 was $7.49. Ryman Healthcare's Shares Outstanding (EOP) for the quarter that ended in Mar. 2025 was 138.0 Mil. Therefore, Ryman Healthcare's market cap for the quarter that ended in Mar. 2025 was $1,033.5 Mil.
Ryman Healthcare's quarterly market cap
increased
from Mar. 2024 ($1,994.1 Mil) to Sep. 2024 ($2,100.6 Mil) but then
declined
from Sep. 2024 ($2,100.6 Mil) to Mar. 2025 ($1,033.5 Mil).
Ryman Healthcare's annual market cap
increased
from Mar. 2023 ($1,508.3 Mil) to Mar. 2024 ($1,994.1 Mil) but then
declined
from Mar. 2024 ($1,994.1 Mil) to Mar. 2025 ($1,063.9 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Ryman Healthcare's Enterprise Value for Today is $2,220.0 Mil.
Ryman Healthcare (OTCPK:RYHTY) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Ryman Healthcare Market Cap Related Terms
Ryman Healthcare Market Cap Historical Data
* Premium members only.
The historical data trend for Ryman Healthcare's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Ryman Healthcare's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ryman Healthcare Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ryman Healthcare's Market Cap distribution charts can be found below:
* The bar in red indicates where Ryman Healthcare's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Ryman Healthcare's Market Cap for the fiscal year that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ryman Healthcare (RYHTY) has a Market Cap of $1,241.2 Mil as of Jun. 24, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Ryman Healthcare and its competitors. According to the industry distribution chart, Ryman Healthcare ranks #103 out of 697 companies in the Healthcare Providers & Services industry, placing it in the top 14.8%.
Is Ryman Healthcare's Market Cap too high?
Ryman Healthcare's current Market Cap is $1,241.2 Mil. The Healthcare Providers & Services industry median Market Cap is 95.30. Ryman Healthcare's value of $1,241.2 Mil is 1202.4% above this industry median. Based on the distribution chart, Ryman Healthcare ranks #103 out of 697 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Ryman Healthcare has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Ryman Healthcare's Market Cap compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ryman Healthcare ranks #103 out of 697 companies for Market Cap. This places Ryman Healthcare in the top 15% of its industry — outperforming the majority of peers. The industry median Market Cap is 95.30. Ryman Healthcare's value of $1,241.2 Mil is 1202.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 95.30, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ryman Healthcare's current Market Cap of $1,241.2 Mil is 1202.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Ryman Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 95.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ryman Healthcare's current Market Cap is $1,241.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ryman Healthcare stock overvalued right now?
Ryman Healthcare (RYHTY) has a current Market Cap of $1,241.2 Mil. The stock's GF Value™ is $17.68, compared to a current price of $6.11 — trading 65.4% below its estimated fair value. The current Market Cap is $1,241.2 Mil and 1202.4% above the Healthcare Providers & Services industry median of 95.30. Ryman Healthcare's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Ryman Healthcare (RYHTY), the current Market Cap is $1,241.2 Mil as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ryman Healthcare (RYHTY) Overvalued in 2026?
Based on GuruFocus' analysis, Ryman Healthcare stock appears to be undervalued.
The current stock price of $6.11 is trading 65.4% below its estimated GF Value™ of $17.68.
Key valuation signals for RYHTY:
Market Cap: $1,241.2 Mil
GF Value™: $17.68 vs. price of $6.11 (65.4% below fair value)
Industry Position: 1202.4% above the Healthcare Providers & Services median (#103 of 697)
No single metric tells the full story. See the RYHTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ryman Healthcare Ltd is a retirement living and aged care provider operating in New Zealand and Australia. It owns and operates integrated retirement villages through its trading subsidiaries, which operate in the aged care and retirement living sector in New Zealand and Australia. The Group operates in a single industry: the provision of integrated retirement living and aged care for older people in New Zealand and Australia. The majority of revenue is derived from Care and village fees, which relate to the provision of accommodation, care and related services to aged care residents and retirement living residents.
70GF Score
Get the complete analysis for RYHTY
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RYHTY has been successfully added to your 
